This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Market Preview: Who Still Wants QE3?

The stock is one of the best performers in the Dow this year, rising nearly 23%, though it's pulled back a bit in the last week since hitting a 52-week high of $48 on Oct. 18. Merck has an eight-quarter streak of beating Wall Street's profit expectations on the line.

The sell side is only mildly bullish on the stock with 11 of the 21 analysts covering Merck at either strong buy (5) or buy (6) and the remainder at hold. The 12-month median price target is $48 vs. Thursday's close at $46.30, but the valuation isn't all that stretched with shares trading at a forward price-to-earnings multiple of 12.4X vs. 13.8X for the S&P 500.

The problem for Merck remains stagnation on the top line as an in-line revenue performance this quarter would represent declines from its total of $12.31 billion in the second quarter and $12.02 billion in the same period a year earlier.

Other early reporters include American Axle & Manufacturing (AXL), Arch Coal (ACI), Comcast Corp. (CMCSA), Coventry Health Care (CVH), Entrecom Communications (ETM), Goodyear Tire (GT), Graham Corp. (GHM), Immunogen (IMGN), Interpublic Group (IPG), Kaydon (KDN), KKR (KKR), Lear Corp. (LEA), Legg Mason (LM), LifePoint Hospitals (LPNT), Magellan Health Services (MGLN), Moody's Corp. (MCO), Newell Rubbermaid (NWL), Oppenheimer Holdings (OPY), Pilgrim's Pride (PPC), Radware (RDWR), Rockwell Collins (COL), Starwood Financial (SFI), TASER International (TASR), and Weyerhaeuser (WY).

The big piece of economic data due Friday morning is the advance estimate of gross domestic product for the third quarter, slated for release at 8:30 a.m. ET. The consensus estimate is for growth of 1.9%, up from 1.3% in the second quarter, according to Briefing.com, whose own projection is a less optimistic 0.8%.

Paul Ashworth, chief North American economist at Capital Economics, is expecting annualized growth to remain flat with the 1.3% pace seen in the second quarter.

"Consumption growth appears to have accelerated and residential investment appears to have been strong. Judging by the rebound in State and local government employment, the public sector may also have contributed positively to growth. However, it appears that business investment actually contracted slightly," he said. "Net trade was probably a small drag on GDP growth too. Finally, inventories were probably a big drag."

Ashworth said he believes the risks to the firm's forecast are on the downside and cited Thursday's durable goods data as further evidence of that.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,013.00 -26.49 -0.16%
S&P 500 1,990.26 -2.11 -0.11%
NASDAQ 4,538.3890 +6.2850 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs